Close

More on BIO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-30.8% Growth)
- Ratings (6.4 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (5/7/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BIO Cash Flow Statement

Click line-items for a historical chart and %
Cash flows from operating activities:
Cash received from customers 1.02B
Cash paid to suppliers and employees -935.59M
Interest paid
Income tax payments -11.09M
Investment proceeds and miscellaneous receipts, net 12.81M
Excess tax benefits from share-based compensation -75K
Net cash provided by operating activities 69.71M
Cash flows from investing activities:
Capital expenditures -56.87M
Proceeds from sale of property, plant and equipment 21K
Payments for acquisitions, net of cash received, and long-term investments
Payments on purchases of intangible assets -6K
Purchases of marketable securities and investments
Sales of marketable securities and investments 42.39M
Maturities of marketable securities and investments 64.04M
(Payments for) proceeds from foreign currency economic hedges, net
Net cash used in investing activities -110.33M
Cash flows from financing activities:
Net borrowings (payments) on line-of-credit arrangements and notes payable
Long-term borrowings
Payments on long-term borrowings -156K
Proceeds from issuance of common stock 6.88M
Debt issuance costs on long-term borrowings
Excess tax benefits from share-based compensation 75K
Net cash (used in) provided by financing activities 3.29M
Effect of foreign exchange rate changes on cash -1.57M
Net decrease in cash and cash equivalents -38.9M
Cash and cash equivalents at beginning of period 457.55M
Cash and cash equivalents at end of period 418.65M
Reconciliation of net income including noncontrolling interests to net cash provided by operating activities:
Net income including noncontrolling interests 30.29M
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities excluding the effects of acquisitions:
Depreciation and amortization 71.67M
Share-based compensation 9.41M
Foreign currency economic hedges, net
Excess tax benefits from share-based compensation -75K
Decrease (increase) in accounts receivable 32.07M
Increase in inventories -50.98M
Increase in other current assets -2.56M
Decrease in accounts payable and other current liabilities -32.56M
Increase in income taxes payable 11K
Other 10.32M
Net cash provided by operating activities 69.71M

Entities mentioned with BIO

View All Entities